Tourmaline Bio said its experimental antibody treatment demonstrated deep reductions in a measure of inflammation often tied ...

WHO members on Tuesday adopted a treaty that outlines how to prepare for and respond to pandemics. One country missing: the U ...

How would you solve the chronic disease epidemic? Here's STAT's extensive new data analysis, and nine ways to tackle the ...

Some are criticizing Biden’s team for not testing him earlier for prostate cancer. But overtesting is a particular concern ...

Regeneron plans to buy 23andMe out of bankruptcy for $256 million, potentially bringing to a close the saga of the consumer ...

Health insurers continue to use algorithms to predict how long patients need intense care — and thus how much care is covered ...

President Trump’s science adviser called for a return to reproducible and transparent research to kickstart stalled ...

As HHMI pauses Hanna Gray fellowship applications, opportunities for young scientists shrink further, making them look ...

The grant termination letters say there are no appeals. Yet dozens of appeals have succeeded as biomedical researchers lobby ...

The past month has been a disastrous chain of events for UnitedHealth Group — which up until recently was a beloved stock on ...

The FDA finally approved Novavax's Covid-19 vaccine, but placed restrictions on it that its two competitors in the U.S. do ...

Prime Medicine, known for its goal of treating hundreds of diseases with CRISPR, says it's narrowing its focus to two. It ...